Inceptua Early Access and Sentynl Therapeutics Inc. announce the launch of the Early Access Program for Nulibry®
October 11, 2022

October 11, 2022
September 27, 2022
September 21, 2022
September 20, 2022
September 20, 2022
September 8, 2022
August 30, 2022
July 7, 2022
June 16, 2022
September 10, 2026
The global pharmacovigilance specialist will help drive one of Africa’s most comprehensive medicines safety initiatives. Qinecsa, the global pharmacov...
September 10, 2026
A new initiative to connect and empower early-career pathologists across Europe Sakura Finetek Europe today announced the launch of the Sakura Patholo...
September 2, 2026
Inceptua Group, a leading global provider of clinical trial supply, related services, and early access programs backed by Vesey Street Capital Partner...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225